School of Mathematics, University of Minnesota Minneapolis, MN, USA.
Evol Appl. 2013 Jan;6(1):54-69. doi: 10.1111/eva.12019. Epub 2012 Nov 16.
We introduce a stochastic branching process model of diversity in recurrent tumors whose growth is driven by drug resistance. Here, an initially declining population can escape certain extinction via the production of mutants whose fitness is drawn at random from a mutational fitness landscape. Using a combination of analytical and computational techniques, we study the rebound growth kinetics and composition of the relapsed tumor. We find that the diversity of relapsed tumors is strongly affected by the shape of the mutational fitness distribution. Interestingly, the model exhibits a qualitative shift in behavior depending on the balance between mutation rate and initial population size. In high mutation settings, recurrence timing is a strong predictor of the diversity of the relapsed tumor, whereas in the low mutation rate regime, recurrence timing is a good predictor of tumor aggressiveness. Analysis reveals that in the high mutation regime, stochasticity in recurrence timing is driven by the random survival of small resistant populations rather than variability in production of resistance from the sensitive population, whereas the opposite is true in the low mutation rate setting. These conclusions contribute to an evolutionary understanding of the suitability of tumor size and time of recurrence as prognostic and predictive factors in cancer.
我们提出了一个随机分支过程模型,用于研究由耐药性驱动的复发性肿瘤中的多样性。在这里,最初下降的种群可以通过产生随机从突变适应性景观中抽取适应性的突变体来逃避某些灭绝。我们使用分析和计算技术的组合,研究了复发肿瘤的反弹生长动力学和组成。我们发现,复发肿瘤的多样性受突变适应性分布的形状强烈影响。有趣的是,该模型的行为取决于突变率和初始种群大小之间的平衡,表现出定性转变。在高突变环境中,复发时间是复发肿瘤多样性的强预测因子,而在低突变率环境中,复发时间是肿瘤侵袭性的良好预测因子。分析表明,在高突变环境中,复发时间的随机性是由小的耐药种群的随机存活驱动的,而不是由敏感种群产生耐药性的可变性驱动的,而在低突变率环境中则相反。这些结论有助于从进化角度理解肿瘤大小和复发时间作为癌症预后和预测因素的适宜性。